Melissa Ann Gimenez is a Houston, Texas based nurse practitioner. Active license number of Melissa Ann Gimenez is 1009219 for Family in Texas. Her current practice location is 7877 Willow Chase Blvd, Houston. Patients can reach her at 832-869-4818 and her NPI number (Unique professional ID assigned by NPPES) is 1447880745. Melissa Ann Gimenez has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Melissa Ann Gimenez speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447880745
NPI Enumeration Date:
25 Jan, 2020
NPI Last Update On:
12 Sep, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Melissa Ann Gimenez are as mentioned below.
License Number
Specialization
State
Status
1009219
Family
Texas
Primary
845263
Registered Nurse
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Melissa Ann Gimenez 2331 Bal Harbour Dr, Missouri City, Texas
Zip:
77459-7210
Phone Number:
832-384-3823
Patients can reach Melissa Ann Gimenez at 7877 Willow Chase Blvd, Houston, Texas or can call to book an appointment on 832-869-4818.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.